|
Clinical trials Methodology/study design
Citations 91-93 of 93 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
Sample size estimations for MRI-monitored trials of MS comparing new vs standard treatments
- M. P. Sormani, M. Rovaris, F. Bagnato, P. Molyneux, P. Bruzzi, C. Pozzilli, D. H. Miller, G. Comi, and M. Filippi
Neurology 2001; 57: 1883-1885.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Evidence-based measurement: Which disability scale for neurologic rehabilitation?
- J. C. Hobart, D. L. Lamping, J. A. Freeman, D. W. Langdon, D. L. McLellan, R. J. Greenwood, and A. J. Thompson
Neurology 2001; 57: 639-644.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Concurrent validity of the MS Functional Composite using MRI as a biological disease marker
- N.F. Kalkers, L. Bergers, V. de Groot, R.H.C. Lazeron, M.A.A. van Walderveen, B.M.J. Uitdehaag, C.H. Polman, and F. Barkhof
Neurology 2001; 56: 215-219.
[Abstract]
[Full text]
[PDF]
|
|
